Cambridge Heart Antioxidant Study

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2004
INTERVENTION: Alpha‐tocopherol 800 IU daily for first 546 patients, alpha‐tocopherol 400 IU daily for remainder versus placebo CONDITION: Cardiovascular diseases: Heart disease ; Circulatory System ; Heart disease PRIMARY OUTCOME: Cardiovascular death and non‐fatal MI as well as non‐fatal MI alone SECONDARY OUTCOME: Not provided at time of registration INCLUSION CRITERIA: Patients with angiographically proven coronary atherosclerosis
Epistemonikos ID: f3229a11de475ded6c588c7bb28c045f815867f0
First added on: Aug 21, 2024